甲状腺功能亢进患者心肌梗死与卒中的发病率及死亡率:韩国全国性队列研究
该韩国全国性队列研究纳入59,021例甲亢患者与1,180,420例年龄性别匹配对照,发现甲亢与心肌梗死(调整HR 1.16,95%CI 1.03-1.30)及缺血性卒中(调整HR 1.12,95%CI 1.04-1.20)风险增加相关,该关联在女性、≥50岁及非肥胖者中显著;甲亢未显著影响心血管事件后死亡率。
要点
- 甲亢与心肌梗死风险增加相关,调整HR 1.16(95%CI 1.03-1.30)。
- 甲亢与缺血性卒中风险增加相关,调整HR 1.12(95%CI 1.04-1.20)。
- 甲亢未显著影响心肌梗死、缺血性卒中及出血性卒中后的死亡率。
核心结论
- 甲亢与心肌梗死和缺血性卒中风险增加相关,独立于心血管危险因素。
- 该关联在年龄≥50岁、女性及非肥胖(BMI<25 kg/m2)者中显著。
- 甲亢未显著影响心血管事件后的死亡率。
研究设计与样本
- 韩国全国性队列研究,纳入59,021例甲亢患者与1,180,420例年龄性别匹配对照,数据来自韩国国民健康保险数据库。
- 血压、体重指数、血糖、胆固醇及吸烟史来自国民健康筛查检查。
- 比较甲亢组与对照组的心肌梗死、卒中发病率及心血管事件后生存率。
主要发现
- 甲亢组较对照组血压、空腹血糖及吸烟率更高,但胆固醇水平更低、肥胖率更低。
- 调整上述差异及心房颤动后,甲亢与心肌梗死风险增加相关,调整HR 1.16(95%CI 1.03-1.30)。
- 调整后甲亢与缺血性卒中风险增加相关,调整HR 1.12(95%CI 1.04-1.20)。
- 按年龄、性别和BMI分层分析中,女性、年龄≥50岁组及非肥胖组(BMI<25 kg/m2)心肌梗死和缺血性卒中风险增加仍显著,而男性、年龄<50岁组及肥胖组(BMI≥25 kg/m2)不显著。
- 出血性卒中风险在甲亢组与对照组间无差异;甲亢患者发生心肌梗死、缺血性卒中及出血性卒中后的死亡率调整HR分别为1.11(95%CI 0.86-1.43,p=0.44)、0.89(95%CI 0.75-1.05,p=0.16)及1.13(95%CI 0.88-1.47,p=0.34)。
关键数值与推荐
- 甲亢与心肌梗死风险的调整HR为1.16(95%CI 1.03-1.30)。
- 甲亢与缺血性卒中风险的调整HR为1.12(95%CI 1.04-1.20)。
- 甲亢患者心肌梗死后死亡率调整HR 1.11(95%CI 0.86-1.43,p=0.44)。
- 甲亢患者缺血性卒中后死亡率调整HR 0.89(95%CI 0.75-1.05,p=0.16)。
- 甲亢患者出血性卒中后死亡率调整HR 1.13(95%CI 0.88-1.47,p=0.34)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: Hyperthyroidism is associated with various cardiovascular risk factors. However, the relationship between hyperthyroidism and myocardial infarction (MI) or stroke has not been fully elucidated; only a few studies have investigated the association of hyperthyroidism with survival after MI or stroke. Methods: We included 59,021 hyperthyroid patients and a control cohort with 1,180,420 age- and sex-matched subjects from the Korean National Health Insurance database. Blood pressure, body mass index (BMI), glucose and cholesterol levels, and smoking history were obtained during National Health screening examination. We compared the incidence of MI, stroke, and survival after cardiovascular events between subjects with hyperthyroidism and the control cohort. Results: Subjects with hyperthyroidism had higher blood pressure, fasting glucose, and smoking rate, but lower cholesterol levels and a lower obesity rate compared with the control cohort. After adjusting these differences, as well as atrial fibrillation, hyperthyroidism was associated with increased risk of MI and ischemic stroke. Adjusted hazard ratios (HRs) for MI and ischemic stroke with hyperthyroidism was 1.16 [95% confidence interval, CI 1.03-1.30] and 1.12 [CI 1.04-1.20], respectively. In age-, sex-, and BMI-stratified analyses, an increased risk of MI and ischemic stroke remained significant in females, the older age group (≥50 years), and nonobese subjects (BMI <25 kg/m2), but not in males, the younger age group (<50 years), and obese subjects (BMI ≥25 kg/m2). The risk of hemorrhagic stroke was not different between subjects with hyperthyroidism and controls. Adjusted HRs for mortality in subjects with hyperthyroidism who developed MI, ischemic stroke, and hemorrhagic stroke were 1.11 ([CI 0.86-1.43], p = 0.44), 0.89 ([CI 0.75-1.05], p = 0.16), and 1.13 ([CI 0.88-1.47], p = 0.34), respectively. Conclusions: Hyperthyroidism is associated with increased risk of MI and ischemic stroke, independent of cardiovascular risk factors. This association is prominent in subjects with age ≥50 years, in females, and in the nonobese group. Hyperthyroidism did not significantly affect the mortality secondary to cardiovascular events.
引用
- Kim HJ, Kang T, Kang MJ, et al. Incidence and Mortality of Myocardial Infarction and Stroke in Patients with Hyperthyroidism: A Nationwide Cohort Study in Korea. Thyroid. 2020. PMID: 32093587. doi:10.1089/thy.2019.0543
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。